Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protein expression in Down syndrome brain.

E Engidawork1, G Lubec

  • 1Department of Pediatrics, University of Vienna, Austria.

Amino Acids
|February 23, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repeated application of Modafinil and Levodopa reveals a drug-independent precise timing of spatial working memory modulation.

Behavioural brain research·2016
Same author

Proteomic analysis of the TerC interactome: Novel links to tellurite resistance and pathogenicity.

Journal of proteomics·2016
Same author

Amino acids: Holding centre stage more strongly than ever, and continuing to spring surprises.

Amino acids·2013
Same author

Influence ofL-arginine on glucose mediated collagen cross link precursors in patients with diabetes mellitus.

Amino acids·2013
Same author

Biological activity of alpha-alkyl-amino acids.

Amino acids·2013
Same author

Racemization rates of amino acids for dating ancient samples.

Amino acids·2013
Same journal

Author Correction: Novel octapeptide containing the RGD sequence as a potential anti-SARS-CoV-2 agent: design, synthesis, and theoretical studies.

Amino acids·2026
Same journal

Polyamines in CNS malignancies: positively charged culprits in the hijacking of neural and immune signaling pathways.

Amino acids·2026
Same journal

The effects of glutamine supplementation on inflammatory and oxidative stress indices in chronic diseases: a systematic review.

Amino acids·2026
Same journal

Reprogramming parasitic signatures into anticancer peptide candidates: in silico discovery of Leishmania major-derived peptides.

Amino acids·2026
Same journal

Effects of taurine on skeletal muscle in senescence-accelerated mice and C2C12 myoblasts and myotubes.

Amino acids·2026
Same journal

Dual functions of thermospermine in plant growth and stress responses.

Amino acids·2026
See all related articles

Down syndrome (DS) involves genetic abnormalities leading to neurological issues. This review explores protein expression changes, suggesting protein interaction dysregulation contributes to DS neuropathology.

Area of Science:

  • Genetics and Molecular Biology
  • Neuroscience
  • Developmental Biology

Background:

  • Down syndrome (DS) is the most frequent chromosomal abnormality, causing intellectual disability and early-onset Alzheimer-type neurodegeneration.
  • The phenotype is traditionally linked to trisomy 21, with genes like APP, SOD1, and S100beta implicated in apoptosis and neuronal loss.
  • The gene dosage hypothesis is debated, with evidence suggesting dysregulation of genes on other chromosomes also contributes to DS pathology.

Purpose of the Study:

  • To review the protein expression profile in Down syndrome.
  • To postulate that aberrant protein expression and interaction are key to DS neuropathology.
  • To identify candidate proteins that may cause or reflect the DS phenotype, particularly brain abnormalities.

Main Methods:

Related Experiment Videos

  • Literature review focusing on protein expression in Down syndrome.
  • Analysis of existing research on gene overexpression and its downstream effects.
  • Discussion of candidate proteins implicated in DS neuropathology.

Main Results:

  • Overexpression of specific genes on chromosome 21 (e.g., APP, SOD1, S100beta) is associated with apoptosis and neuronal loss.
  • Evidence challenges the sole reliance on the gene dosage hypothesis, indicating broader genetic dysregulation.
  • Candidate proteins are identified that may directly cause or reflect the neurological phenotype in DS.

Conclusions:

  • Protein expression abnormalities and altered protein interactions are likely central to the neuropathology of Down syndrome.
  • Further research into protein profiles can elucidate the mechanisms underlying DS brain abnormalities.
  • Understanding these protein-level changes is crucial for developing targeted therapeutic strategies for DS.